209 related articles for article (PubMed ID: 18984467)
1. Stellate cell contraction: role, regulation, and potential therapeutic target.
Soon RK; Yee HF
Clin Liver Dis; 2008 Nov; 12(4):791-803, viii. PubMed ID: 18984467
[TBL] [Abstract][Full Text] [Related]
2. [Ca2+]i-independent contractile force generation by rat hepatic stellate cells in response to endothelin-1.
Melton AC; Datta A; Yee HF
Am J Physiol Gastrointest Liver Physiol; 2006 Jan; 290(1):G7-13. PubMed ID: 16123199
[TBL] [Abstract][Full Text] [Related]
3. Increased contractility of hepatic stellate cells in cirrhosis is mediated by enhanced Ca2+-dependent and Ca2+-sensitization pathways.
Iizuka M; Murata T; Hori M; Ozaki H
Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G1010-21. PubMed ID: 21393429
[TBL] [Abstract][Full Text] [Related]
4. Blebbistatin inhibits contraction and accelerates migration in mouse hepatic stellate cells.
Liu Z; van Grunsven LA; Van Rossen E; Schroyen B; Timmermans JP; Geerts A; Reynaert H
Br J Pharmacol; 2010 Jan; 159(2):304-15. PubMed ID: 20039876
[TBL] [Abstract][Full Text] [Related]
5. Myosin mediates contractile force generation by hepatic stellate cells in response to endothelin-1.
Saab S; Tam S; Tran Bi; Melton A; Tangkijvanich P; Wong H; Yee H
J Biomed Sci; 2002; 9(6 Pt 2):607-12. PubMed ID: 12432226
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 in portal hypertension: The intricate role of hepatic stellate cells.
Ezhilarasan D
Exp Biol Med (Maywood); 2020 Oct; 245(16):1504-1512. PubMed ID: 32791849
[TBL] [Abstract][Full Text] [Related]
7. Quantitative real-time measurement of endothelin-1-induced contraction in single non-activated hepatic stellate cells.
Dohi N; Yamaguchi M; Hase R; Suzuki R; Wakabayashi Y; Nishiyama R; Saito SY; Ishikawa T
PLoS One; 2021; 16(8):e0255656. PubMed ID: 34343209
[TBL] [Abstract][Full Text] [Related]
8. Fibronectin stimulates endothelin-1 synthesis in rat hepatic myofibroblasts via a Src/ERK-regulated signaling pathway.
Zhan S; Chan CC; Serdar B; Rockey DC
Gastroenterology; 2009 Jun; 136(7):2345-55.e1-4. PubMed ID: 19505428
[TBL] [Abstract][Full Text] [Related]
9. HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects.
Klein S; Van Beuge MM; Granzow M; Beljaars L; Schierwagen R; Kilic S; Heidari I; Huss S; Sauerbruch T; Poelstra K; Trebicka J
J Hepatol; 2012 Dec; 57(6):1220-7. PubMed ID: 22878469
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia and hypoxia-inducible factor 1α: potential links between angiogenesis and fibrogenesis in hepatic stellate cells.
Troeger JS; Schwabe RF
Liver Int; 2011 Feb; 31(2):143-5. PubMed ID: 21176093
[No Abstract] [Full Text] [Related]
11. The use of nanoparticles to deliver nitric oxide to hepatic stellate cells for treating liver fibrosis and portal hypertension.
Duong HT; Dong Z; Su L; Boyer C; George J; Davis TP; Wang J
Small; 2015 May; 11(19):2291-304. PubMed ID: 25641921
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase.
Iwakiri Y
Clin Mol Hepatol; 2015 Dec; 21(4):319-25. PubMed ID: 26770919
[TBL] [Abstract][Full Text] [Related]
13. Distinct roles for non-muscle myosin II isoforms in mouse hepatic stellate cells.
Liu Z; Van Rossen E; Timmermans JP; Geerts A; van Grunsven LA; Reynaert H
J Hepatol; 2011 Jan; 54(1):132-41. PubMed ID: 20932596
[TBL] [Abstract][Full Text] [Related]
14. Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques.
Tacke F; Weiskirchen R
Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):67-80. PubMed ID: 22149583
[TBL] [Abstract][Full Text] [Related]
15. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
Carloni V; Luong TV; Rombouts K
Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349
[TBL] [Abstract][Full Text] [Related]
16. Cellular sources of extracellular matrix in hepatic fibrosis.
Wells RG
Clin Liver Dis; 2008 Nov; 12(4):759-68, viii. PubMed ID: 18984465
[TBL] [Abstract][Full Text] [Related]
17. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
[TBL] [Abstract][Full Text] [Related]
18. Inflammation and hepatic fibrosis.
Bissell DM
Semin Liver Dis; 2010 Aug; 30(3):211-4. PubMed ID: 20665373
[No Abstract] [Full Text] [Related]
19. [Role of Rho-Rock pathways induced by angiotensin II in hepatic stellate cell contraction].
Zhang XL; Xiao B; Li X; Huang ML; Meng Y; Li YF; Wang YY; Song WB
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(34):2422-6. PubMed ID: 19087721
[TBL] [Abstract][Full Text] [Related]
20. Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice.
van Beuge MM; Prakash J; Lacombe M; Gosens R; Post E; Reker-Smit C; Beljaars L; Poelstra K
J Pharmacol Exp Ther; 2011 Jun; 337(3):628-35. PubMed ID: 21383021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
